LH
Recent studies in our laboratory have demonstrated that stimulatory action of estradiol on LH release may be mediated by the medial amygdala and the bed nucleus of stria terminalis, both being included in the limbic structure, as well as the arcuate nucleus of the hypothalamus. A minute amount of estradiol benzoate implanted in the medial amygdala or the bed nucleus of stria terminalis on the night of diestrus 2 in the 4-day cyclic rat which was treated with progesterone to prevent expected ovulation overcame the inhibitory effect of progesterone, inducing LH release on the following day (Terasawa and Kawakami, 1974 ). In the 5-day cyclic rat, similar implantation in those areas at 12:00 on the day of diestrus 2 advanced ovulation by 1 day . The same experiment showed that the implantation in the arcuate nucleus was also effective, however, that in the medial preoptic area was consistently ineffective to induce LH release and subsequent ovulation.
The lack of responsivity of the medial preoptic area to estradiol in relation to inducing LH release had also been shown indirectly. Acute horizontal transection at the level of anterior commissure, just above the medial preoptic area, or transection of the stria terminalis or lesion of the amygdaloid nucleus, but leaving the preopticarcuate region being left intact, on the morning of proestrus prevented ovulation which results from stimulatory feedback action of estrogen on the CNS (Velasco and Taleisnik, 1971; Kawakami and Terasawa, 1972) . Similarly, the stimulatory effect of subcutaneous injection of estradiol benzoate et al.
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Japon. December 1975 on ovulation in the progesterone treated 4-day cyclic rat or in the 5-day cyclic rat in diestrus 2 was blocked by acute destruction of amygdaloid fibers or the bed nucleus of stria terminalis Terasawa and Kawakami, 1974) . Nevertheless, electrical stimulation of the medial preoptic area could induce facilitation of the arcuate neuronal activity, LH release and subsequent ovulation on each day of the cycle, and the effectiveness was high when stimulation was applied in the afternoon (Kawakami and Terasawa, 1970; Kawakami et al., 1971) .
From those observations, it has been hypothesized that it is the medial amygdala and the bed nucleus of stria terminalis which stimulate the LH surge every 4 or 5 days in response to estradiol rising every 4 or 5 days, but it is the medial preoptic area which gives the neural stimuli of the medial amygdala or the bed nucleus of stria terminalis the nature of circadian periodicity. Although the CNS circadian rhythm is intrinsic, and independent of feedback effect (Richter, 1971) , the study of Lawton and Smith (1970) suggested a certain modiIn this regard, we have examined the effect of estrone, whose secretion undergoes circadian rhythm (Baranczuk and Greenwald, 1973; Horikoshi and Suzuki, 1974) , on the medial preoptic activity with special reference to inducement of LH release. Furthermore, it is another problem in this study to know the possible neurotransmitter of inputs from the medial amygdala and bed nucleus of stria terminalis for the activation of the medial preoptic area to facilitate LH release. estradiol benzoate was drawn to the tip of the inner cannula, which was made of stainless tube of 0.4mm in outer diameter, after being melt on the pilex glass. Animals served as estrone experiment were divided into 4 groups. The first group of animals was implanted with estrone at 12:00 on Day 0 simultaneously with estradiol injection, and the second, the third and the fourth groups were implanted with estrone at 12:00 on the first (Day 1), the second (Day 2) or the third (Day 3) day after the estradiol injection, respectively.
Implantation of estradiol benzoate was only performed on Day 3. Dopamine (dopamine hydrochloride, Wako Purechemical Ind.) or norepinephrine (Sankyo Co.) was implanted, after packed into the inner, cannula on Day 3. Either the nonimplanted control animals or the implanted animals with those substances were bled at 12: 00 and 18:00 on the day of implantation.
Serum LH concentration was measured by double antibody radioimmunoassay.
The assay procedure was based upon the methods described by Niswender et al. (1968) and by NIAMDD instructions.
The amount of hormone was expressed in the term of NIH-LH-S1.
Histological sections of the brains were made to examine the sites of implantations.
Results
1. Effect of estrone or estradiol implantation into the medial preoptic area.
The high concentration of serum LH observed in the ovariectomized rat was slightly depressed at 18: 00 on the day of injection of estradiol benzoate at 12:00 (Day 0), and this was more evident on the afternoon of the following day (Day 1). On the second and the third days (Day 2 and Day 3), the serum concentration of LH at 18:00 became higher than those at 12: 00, indicating a circadian LH release by stimulatory feedback action of estradiol injected. Implantation of crystalline estrone into the medial preoptic area at 12: 00 on the second or the third day after the injection of estradiol induced an increase of serum LH level in the afternoon, compared with those in the non-implanted control animals on the same afternoon. Implantation of estradiol benzoate into the preoptic area was not effective to increase serum LH level at 18:00. The effect of estrone was rather inhibitory to LH release on the afternoon of the day of estrogen. injection and of the following day; the serum LH concentrations at 18:00 on each day was lower than those in non-implanted controls (Table 1) .
2. Effect of dopamine or norepinephrine implantation into the medial preoptic area.
In the animals implanted with dopamine into the medial preoptic area, the serum concentration of LH at 18:00 was significantly higher than that in non-implanted control animals. However, in the animals with implantation of norepinephrine, the serum concentration of LH at 18:00 was significantly lower than that in the nonimplanted controls (Table 1) . It is clear that dopamine facilitates the release of LH, while norepinephrine suppresses it.
Discussion
The result of the present experiment clearly demonstrates that the medial preoptic area is not responsive to estradiol concerning gonadotropin release, in spite of high uptake of tritiated estradiol. Kato and Villee (1967) , and Luttge and Whalen (1970) have demonstrated, however, that after the injection of estradiol, significant amounts of estrone can be found in selected regions of the brain. Furthermore, in the preopticanterior hypothalamic areas, the radioactivity chromatographed as estrone was only 9-10%, in contrast with over 20% in the median eminence-posterior hypothalamic areas. The preoptic anterior hypothalamic area retained a considerable amount of estrone, which was less than cerebral peduncle or the posterior hypothalamus did (Luttge and Whalen, 1972) . These facts seem to indicate a possibility that estradiol taken up in the brain tissue becomes effective after it is converted into estrone and the medial preoptic area has the estrone receptor, which could not be saturated by estradiol. estrone. This postulate may be supported by the studies of Hilliard et al. (1967) , who reported the importance of progestin in prolongation of preovulatory release of LH in the copulated rabbit.
It should be noticed from the unsuccessfulness in inducing ovulation in the cycling rat as described following that the excitation of the medial preoptic area alone is not sufficient for inducing ovulatory LH release. The implantation of estrone in the medial preoptic area at 12:00 on diestrus day 2 advanced vaginal cycle in 6 out of 14 animals, but induced early ovulation in only 2 animals on the medial preoptic neurons. According to Palkovits's experiment (personal communication), dopamine cell bodies lie in the medial part of the medial preoptic area and their axons extend to the central part of the medial preoptic area to terminate there. That is supported, by the fact that the reduction of dopamine in the medial preoptic area was very slight, approximately 20%, after the lesion of substantia nigra.
He also demonstrated that the bed nucleus of stria terminalis was extremely high in dopamine content as so the median eminence, although the cell bodies could not be ascertained in the area. The finding suggesting that dopamine is implicated as the possible transmitter at the level of the medial preoptic area is quite interesting. Experimental results, on one hand, supported the norepinephrine as neurotransmitter for stimulating LH-RH release (Rubinstein and Sawyer, 1970; Tima and FlerkO, 1974; Sawyer, 1975) , but on the other hand indicated the implication of dopamine in this process (Schneider and McCann, 1969a, b; Kamberi et al., 1969; Kordon and Glowinski, 1969) . However, those results are not necessarily incompatible with each other, if one assumes the implication of at least two neurotransmitters, the one at the site of the medial preoptic neurons and the other at the site of LH-RH neurons.
In the ovariectomized estradiol primed rat norepinephrine acts at the medial preoptic area to suppress LH release in the ovariectomized estradiol primed rats as shown in the present experiment. In contrast, in the constant estrous rat induced by continuous illumination, norepinephrine implantation into the medial preoptic area facilitated release of LH (Kawakami et al., unpublished observation) . These facts may indicate that the different effects of norepinephrine on the gonadotropin release depends on the hormonal circumstance. The preoptic area is extensively innervated by terminals from the ascending ventral noradrenergic pathway originating from the area out of the hypothalamus.
Similarly, the same implantation on diestrus day 3 Vol.22, No.6 LH SURGE BY PREOPTIC ESTRONE OR DOPAMINE was effective to advance vaginal cycle, inducing cornified smear on the following day, in 4 out of 8 rats, but ovulation occurred only in 2 of the 4 rats. The incidence of advancement of vaginal cycle and ovulation is larger than that observed in the implantation of estradiol in the medial preoptic area, but is much smaller than that in the implantation of estradiol in the medial amygdala or the bed nucleus of stria terminalis effect on expected ovulation of progesterone injected at 11:00 on diestrus day 2. There are two possibilities concerning the dopamine action on the medial preoptic area.
One is that dopamine acts as an mediator for the stimulatory action of estrogen.
For instance, Rosenfeld and O'Malley (1970) reported that the stimulatory effect of estradiol on uterine adenyl cyclase activity could be prevented by DLpropranolol.
Although similar observation has not been done in the brain tissues, it was observed that the stimulatory effect of dopamine implantation in the medial preoptic area on the arcuate multiunit activity occurred more acutely and sharply when it was implanted with estradiol than when not. Therefore, the concept that a certain amount of catecholamine may serve as a mediator for steroid hormone action on the brain tissue seems to be quite interesting.
The other possibility is that dopamine acts as the neurotransmitter in the lower brain stem (Ungerstedt, 1971) . Furthermore, Palkovits (1975, personal communication) demonstrated a possibility, as in the case of dopamine, that a certain amount of norepinephrine in the medial preoptic area is supplied by the fibers from the adjacent area such as the bed nucleus of stria terminalis or septal nucleus, which has a high content of norepinephrine that could not be absolutely reduced by the lesion of the locus coeruleus. Therefore, either of both noradrenergic pathways can influence the medial preoptic activity.
